IRLAB Therapeutics AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	81.86	66.92	111.31	252.78	401.9
Cash & Short-Term Investments	81.86	66.92	111.31	252.78	401.9
Cash Growth	22.33%	-39.88%	-55.96%	-37.10%	45.08%
Accounts Receivable	4.01	-	-	3.32	4.47
Other Receivables	-	10.08	9.17	8.9	6.27
Receivables	4.01	10.08	9.17	12.22	10.74
Prepaid Expenses	-	2.2	2.8	3.34	2.28
Other Current Assets	-0	0.37	0.31	0.35	6.52
Total Current Assets	85.87	79.56	123.59	268.68	421.44
Property, Plant & Equipment	5.47	9.79	6.67	8.01	8.35
Other Intangible Assets	46.86	46.86	46.86	46.86	42.4
Long-Term Deferred Charges	-	-	-	-	0.26
Other Long-Term Assets	-	-0	-	-0	-0
Total Assets	138.21	136.21	177.12	323.56	472.45
Accounts Payable	-	9.94	10.52	10.03	12.3
Accrued Expenses	-	11.68	14.91	13.44	5.84
Short-Term Debt	26.42	53.47	-	-	-
Current Portion of Leases	3.54	3.42	2.94	3.6	3.03
Current Unearned Revenue	-	-	-	-	42.58
Other Current Liabilities	77.54	21.54	8.35	5.28	5.65
Total Current Liabilities	107.49	100.04	36.73	32.34	69.4
Long-Term Debt	-	-	24.51	-	-
Long-Term Leases	-	3.54	0.12	0.38	3.57
Total Liabilities	107.49	103.58	61.36	32.72	72.97
Common Stock	1.7	1.04	1.04	1.04	1.04
Additional Paid-In Capital	800.41	690.21	690.21	690.21	685.45
Retained Earnings	-771.39	-658.61	-575.48	-400.41	-287
Comprehensive Income & Other	-	0	-	-	-
Shareholders' Equity	30.72	32.64	115.76	290.83	399.48
Total Liabilities & Equity	138.21	136.21	177.12	323.56	472.45
Total Debt	29.95	60.42	27.57	3.98	6.6
Net Cash (Debt)	51.91	6.5	83.74	248.8	395.3
Net Cash Growth	699.06%	-92.24%	-66.34%	-37.06%	44.23%
Net Cash Per Share	0.77	0.13	1.61	4.80	7.64
Filing Date Shares Outstanding	84.94	51.87	51.87	51.87	51.75
Total Common Shares Outstanding	84.94	51.87	51.87	51.87	51.75
Working Capital	-21.62	-20.48	86.86	236.34	352.04
Book Value Per Share	0.36	0.63	2.23	5.61	7.72
Tangible Book Value	-16.14	-14.23	68.9	243.97	357.08
Tangible Book Value Per Share	-0.19	-0.27	1.33	4.70	6.90
Machinery	-	7.02	6.82	6.53	3.65
Leasehold Improvements	-	0.12	0.12	0.12	0.12

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.